COURTNEY KRAUSE: Open Payments
NPI 1740967181 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,651 in 61 payments from 19 companies in 2025. Trend: 2023 $177 · 2024 $1,136 · 2025 $2,651
Food & beverage: $1,294Long term medical supply or device loan: $1,164Education: $193
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $1,351 |
| Incyte Corporation | 6 | $269 |
| JAZZ PHARMACEUTICALS INC. | 4 | $197 |
| Gilead Sciences, Inc. | 5 | $155 |
| AstraZeneca Pharmaceuticals LP | 5 | $151 |
| E.R. Squibb & Sons, L.L.C. | 1 | $128 |
| ABBVIE INC. | 2 | $66 |
| PFIZER INC. | 3 | $62 |
| Daiichi Sankyo Inc. | 3 | $59 |
| Geron Corporation | 1 | $43 |
Products named: KISQALI, ZEPZELCA, Trodelvy, REBLOZYL, Niktimvo, ENHERTU, LYNPARZA, IMBRUVICA.
Industry payments across MI — which companies pay providers there.
